Skip to main content

The Global Kidney Cancer Drugs Market Is Witnessing High Growth Owing To the Increasing Prevalence of Kidney Cancer Cases in the World

 


Market Overview:

Kidney cancer is a serious medical condition. There are several types of the disease, including medullary and sarcoma, which are less common but highly aggressive. They develop in the soft tissue surrounding the kidney, as well as in the fat that surrounds it. Surgical removal of the affected organ is the standard treatment for this type of cancer. However, if the disease has spread to other organs or spreads beyond the kidney, chemotherapy or systemic therapy may be needed. A biopsy is another test for kidney cancer. It involves inserting a thin needle into a tumor and looking through the tissue under a microscope to detect cancer cells. Biopsies aren't always accurate, and the healthcare provider may not recommend them. If the tumor has spread to lymph nodes or is large, a biopsy may be performed. This will allow the doctor to evaluate the tumor's location and the extent of its spread and determine its stage and aggressiveness.

Competitive Landscape:

Major players operating in the global kidney cancer drugs market include Quest Diagnostics Incorporated, Illumina Inc, Rosetta Genomics, Sysmex Corporation, NanoString Technologies Inc, NeoGenomics Laboratories, Myriad Genetics Inc, Argos Therapeutics, Prometheus Laboratories, Immatics Biotechnologies, Aveo Pharmaceuticals, Abbott Laboratories, Onyx, Cipla Limited, Roche, Eisai, Bristol-Myers Squibb, Thermo Fisher Scientific Inc, Amgen, Active Biotech, GlaxoSmithKline Plc, Genentech Inc., F. Hoffmann-La Roche Ag, Exelixis Inc, Novartis International AG, Pfizer Inc., and Bayer AG.

Key Market Drivers:

The increasing incidence of kidney cancer cases in the world is expected to augment the growth of the global kidney cancer drugs market. For instance, according to Cancer.Net, in 2020, around 431,288 individuals in the world were suffering from kidney cancer. Targeted drug therapy uses drugs or substances to attack the cancer cells in a specific area of the body. This can reduce side effects caused by the drugs while still killing the cancer cells. Anti-angiogenic agents block the growth of the blood vessels feeding the tumor. A multikinase inhibitor can stop the growth of cancer cells, while a tyrosine kinase inhibitor works by blocking an enzyme that helps the cancer cells grow. Increasing treatment launches by key players are estimated to enhance the growth of the global kidney cancer drugs market. 

Covid-19 Impact Analysis

During the COVID-19 pandemic, the increasing focus on the virus-infected cases affected the growth of the global kidney cancer drugs market.  Moreover, sudden stress on the healthcare sector also impacted the market growth.

Key Takeaways

·         North America is expected to dominate the growth of the global kidney cancer drugs market, owing to the increasing prevalence of kidney cancer cases in the region. For instance, according to Cancer.Net, in 2020 around 79,000 adults in the U.S. were diagnosed with kidney cancer.

·         The Asia Pacific is estimated to witness high growth in the global kidney cancer drugs market, owing to the increasing expansion of cancer hospitals in the region. For instance, according to the Indian Cancer Society, India has around 27 dedicated cancer hospitals currently.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more